347850 — DND Pharmatech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for DND Pharmatech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	75,958	25,504	15,642	30,014	47,889
Net Total Accounts Receivable
Net Total Receivables	133	438	1,521	5,672	2,101
Prepaid Expenses
Total Current Assets	81,692	33,355	19,565	39,794	50,988
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,966	3,024	6,422	7,729	5,636
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	251,109	93,642	79,204	97,500	97,539
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	66,859	54,923	7,487	11,115	5,419
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	119,000	84,201	32,554	27,388	18,046
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	132,109	9,440	46,650	70,112	79,494
Total Liabilities & Shareholders' Equity	251,109	93,642	79,204	97,500	97,539
Total Common Shares Outstanding